News Releases Jefferies Healthcare Conference Wednesday, June 07, 2023 Listen to Webcast Keyword Search Year None20232022202120202019 Date Title 06/02/23 Optinose to Present at the Jefferies Healthcare Conference 05/11/23 Optinose Reports First Quarter 2023 Financial Results and Operational Updates 05/04/23 Optinose Announces FDA Acceptance of Supplemental New Drug Application for XHANCE 05/01/23 Optinose Announces Reporting Date for First Quarter 2023 Financial Results 04/18/23 Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 04/12/23 Optinose to Present at the Needham Virtual Healthcare Conference 03/07/23 Optinose Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Operational Highlights 02/28/23 Optinose Announces Reporting Date for Fourth Quarter 2022 Financial Results 02/21/23 Optinose Submits Supplemental New Drug Application for XHANCE Label Expansion 01/31/23 Optinose Announces CEO Transition and Business Update